Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 Aug;43(8):735–738. doi: 10.1136/jnnp.43.8.735

CFS hydroxylase cofactor levels in some neurological diseases.

A C Williams, R A Levine, T N Chase, W Lovenberg, D B Calne
PMCID: PMC490647  PMID: 6448917

Abstract

The cerebrospinal fluid concentration of hydroxylase cofactor has been measured in patients with Parkinson's disease, the Shy-Drager and Steele-Richardson syndromes, adult onset focal dystonia, essential tremor, Huntington's disease and presenile dementia. The results were compared with age matched controls and low values were demonstrated for all disease groups studied except for focal dystonia.

Full text

PDF
735

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
  2. Bird E. D., Iversen L. L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain. 1974 Sep;97(3):457–472. doi: 10.1093/brain/97.1.457. [DOI] [PubMed] [Google Scholar]
  3. Bullard W. P., Guthrie P. B., Russo P. V., Mandell A. J. Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain. J Pharmacol Exp Ther. 1978 Jul;206(1):4–20. [PubMed] [Google Scholar]
  4. Chase T. N. Biochemical and pharmacologic studies of dystonia. Neurology. 1970 Nov;20(11):122–130. doi: 10.1212/wnl.20.11_part_2.122. [DOI] [PubMed] [Google Scholar]
  5. Coleman M. Preliminary remarks on the L-dopa therapy of dystonia. Neurology. 1970 Nov;20(11):114–121. doi: 10.1212/wnl.20.11_part_2.114. [DOI] [PubMed] [Google Scholar]
  6. Crapper D. R., Krishnan S. S., Dalton A. J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science. 1973 May 4;180(4085):511–513. doi: 10.1126/science.180.4085.511. [DOI] [PubMed] [Google Scholar]
  7. Davies P., Maloney A. J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976 Dec 25;2(8000):1403–1403. doi: 10.1016/s0140-6736(76)91936-x. [DOI] [PubMed] [Google Scholar]
  8. Guroff G., Rhoads C. A., Abramowitz A. A simple radioisotope assay for phenylalanine hydroxylase cofactor. Anal Biochem. 1967 Nov;21(2):273–278. doi: 10.1016/0003-2697(67)90189-3. [DOI] [PubMed] [Google Scholar]
  9. Kaufman S., Berlow S., Summer G. K., Milstien S., Schulman J. D., Orloff S., Spielberg S., Pueschel S. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N Engl J Med. 1978 Sep 28;299(13):673–679. doi: 10.1056/NEJM197809282991301. [DOI] [PubMed] [Google Scholar]
  10. Kaufman S., Holtzman N. A., Milstien S., Butler L. J., Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975 Oct 16;293(16):785–790. doi: 10.1056/NEJM197510162931601. [DOI] [PubMed] [Google Scholar]
  11. Kettler R., Bartholini G., Pletscher A. In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature. 1974 May 31;249(456):476–478. doi: 10.1038/249476a0. [DOI] [PubMed] [Google Scholar]
  12. LANCE J. W., SCHWAB R. S., PETERSON E. A. Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain. 1963 Mar;86:95–110. doi: 10.1093/brain/86.1.95. [DOI] [PubMed] [Google Scholar]
  13. Leeming R. J., Blair J. A. Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism. Lancet. 1979 Mar 10;1(8115):556–556. doi: 10.1016/s0140-6736(79)90981-4. [DOI] [PubMed] [Google Scholar]
  14. Leeming R. J., Blair J. A., Melikian V., O'Gorman D. J. Biopterin derivatives in human body fluids and tissues. J Clin Pathol. 1976 May;29(5):444–451. doi: 10.1136/jcp.29.5.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lovenberg W., Levine R. A., Robinson D. S., Ebert M., Williams A. C., Calne D. B. Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science. 1979 May 11;204(4393):624–626. doi: 10.1126/science.432666. [DOI] [PubMed] [Google Scholar]
  16. Morgan M. H., Hewer R. L., Cooper R. Effect of the beta adrenergic blocking agent propranolol on essential tremor. J Neurol Neurosurg Psychiatry. 1973 Aug;36(4):618–624. doi: 10.1136/jnnp.36.4.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tabaddor K., Wolfson L. I., Sharpless N. S. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia. Neurology. 1978 Dec;28(12):1254–1258. doi: 10.1212/wnl.28.12.1254. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES